Istanbul Medipol University
Istanbul, Beykoz, 34810, Turkey (Türkiye)
NCT Number: NCT03629938
The aim of the study is, to evaluate and classificate the medial longitudinal arch height in adult individuals. Aged between 18-40 years,350 adults who are voluntarily participate is going to be evaluate with Feiss Line(FL), Navicular Drop(ND) and Longitudinal Arch Angle(LAA) in subtalar neutral and resting position. Maximum, minimum values are going to be calculated. The 95% and 68% prediction intervals will be used as cut off limits.
Looking for future studies?
Notify Me18 year–40 year
All sexes
Observational
Istanbul, Beykoz, 34810, Turkey (Türkiye)
The aim of the study is, to evaluate and classificate the medial longitudinal arch height in adult individuals.
Aged between 18-40 years,350 adults who are voluntarily participate is going to be evaluate with Feiss Line(FL), Navicular Height(NH) and Longitudinal Arch Angle(LAA) in subtalar neutral and resting position. Maximum, minimum values are going to be calculated.
Participant's height, weight and foot length, from posterior aspect of calcaneus to the longest toe's tip, will be measured. Center of the medial malleolus, the navicular tuberosity and the head of the first metatarsal bone will be marked with a CD marker. With these landmarks in foot's relaxed position, neutrally, FL, NH and LAA will be measured by a ruler.
Feiss Line is a drawn line between the center of the medial malleolus to the head of the first metatarsal bone and then perpendicular line distance between this line and the navicular tuberosity will be drawn.The vertical line between the ground and the tubercle indicates Navicular Height. Center of goniometer placed at the navicular tuberosity then goniometer arms follow the medial malleolus and the head of the first metatarsal bone, degree between two arms indicates Longitudinal Arch Angle.
FL, NH, LAA mean values will be calculated. The 95% and 68% prediction intervals will be used as cut off limits.
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
evaluation and classification of medial longitudinal arch height of foot in adults
Time frame: 10 days
Navicular Height(NH) mean value, Center of the medial malleolus, the navicular tuberosity and the head of the first metatarsal bone will be marked with a CD marker. With these landmarks in foot's relaxed position, neutrally NH will be measured by a ruler.
The vertical line between the ground and the tubercle indicates Navicular Height. After all data collection, the data will be entered into the Statistical Package for the Social Sciences (SPSS) and the average value calculated.
Time frame: 10 days
Mean value differences between male and female will be compared statistically with the Statistical Package for the Social Sciences (SPSS) program.
Time frame: 10 days
Correlation of arc measurements and standing length will be correlated statistically with the Statistical Package for the Social Sciences (SPSS) program.
Time frame: 10 days
After average values calculated, cut off values will be generated from the data obtained from the arch height in standard, healthy individuals.
Istanbul Medipol University Hospital
Other
Erişkinlerde Ayak Medial Longitudinal Ark Yüksekliğinin Değerlendirilmesi ve Sınıflandırılması
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07632924
Congenital Abnormalities, Congenital, Hereditary, and Neonatal Diseases and Abnormalities
Malatya, Turkey (Türkiye)
View Trial DetailsNCT07326020
Congenital Abnormalities, Congenital, Hereditary, and Neonatal Diseases and Abnormalities
Ankara, Turkey (Türkiye)
View Trial DetailsNCT07426887
Congenital Abnormalities, Congenital, Hereditary, and Neonatal Diseases and Abnormalities
Sialkot, Punjab Province, Pakistan
View Trial DetailsNCT07123753
Congenital Abnormalities, Congenital, Hereditary, and Neonatal Diseases and Abnormalities
Gaziantep, Nizip, Turkey (Türkiye)
View Trial Details